Business
Roivant to Present at Upcoming Investor Conferences
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, May 19, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) will participate in four upcoming
About this update from Roivant Sciences Ltd.
[{"type":"text","content":"BASEL, Switzerland and LONDON and NEW YORK and BOSTON, May 19, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) will participate in four upcoming healthcare investor conferences: UBS Global Healthcare Conference in New York City on Monday, May 23 at 9:15 a.m. EDT. CEO Matt Gline will present.H.C. Wainwright Global Investment Conference in Miami on Tuesday, May 24 at 8:30 a.m. EDT. CFO Richard Pulik will participate in a fireside chat.Jefferies Healthcare Conference in New York City on Wednesday, June 8 at 2:00 p.m. EDT. CEO Matt Gline will participate in a fireside chat.Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, CA on Tuesday, June 14 at 8:40 a.m. PDT / 11:40 a.m. EDT. CFO Richard Pulik and President and Chief Investment Officer Mayukh Sukhatme will participate in a fireside chat. A live webcast of each presentation and fireside chat will be available under “Events & Presentations” on the Investors section of the Roivant website at https://investor.roivant.com/news-events/events, and archived recordings will be available after each presentation. About Roivant SciencesRoivant's mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity. Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch 'Vants' – nimble and focused biopharmaceutical and health technology companies. For more information, please visit www.roivant.com. Roivant Sciences Forward-Looking Statements This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (the \"Securities Act\"), and Section 21E of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), which are usually identified by the use of words such as \"anticipate,\" \"believe,\" \"continue,\" \"could,\" \"estimate,\" \"expect,\" \"intends,\" \"may,\" \"might,\" \"plan,\" \"possible,\" \"potential,\" \"predict,\" \"project,\" \"should,\" \"would\" and variations of such words or similar expressions. The words may identify forward-looking statements, but the absence of these words does not mean that a statement is not f...